This episode is a discussion between ⁠Rahmad Akbar, Senior Data Scientist in Antibody Design at Novo Nordisk and Murat Tunaboylu⁠, Co-Founder and CEO of Antiverse⁠.

You will learn:

  • The impact antibody design has on the world.
  • How AI is helping to push antibody design forward, bringing new therapies to patients.
  • What will antibody design look like in the future?


Rahmad's LinkedIn page.

Rahmad's Personal Website.

Antibody Origami: Here.

Rahmad's Previous and Existing Team: Victor Greiff (GreiffLab). Paolo Marcatili, Ludovica Beltrame, Rasmus Høiberg-Nielsen (Antibody Design at Novo Nordisk).


"And a big shout out to budding antibody designers (scientists) everywhere especially from my home country Indonesia!' - Rahmad.

Be sure to like, rate and review the podcast if you enjoyed this episode!

Visit our website: https://www.antiverse.io/

Follow us: LinkedIn:⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/company/antiverse/⁠⁠⁠⁠⁠⁠⁠ X: ⁠⁠⁠⁠⁠⁠⁠https://twitter.com/AntiverseHQ⁠⁠

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Murat Tunaboylu. Innehållet i podden är skapat av Murat Tunaboylu och inte av, eller tillsammans med, Poddtoppen.